x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:08:01

Jefferies London: Jefferies Global Chairman of...

BiotechTV - News ·

2025/11/18

He shares his take on the capacity for pharma to do more buying, and list his favorite areas of science, which include I&I, CNS/Neurology, and modalities such as bi-specifics and tri-specifics.

en-us

00:11:35

Jefferies London: Chief Scientific Officer Tony Wood...

BiotechTV - News ·

2025/11/18

He mentions momelotinib, Blenrep, B7-H3, depemokimab, efimosfermin, IL-33, TSLP, and more. Plus, GSK's dealmaking strategy.

en-us

00:10:41

Jefferies London: Zymeworks had double-news during...

BiotechTV - News ·

2025/11/18

CEO Kenneth Galbraith explains the new dual business focus and walks us through the topline HER2 data.

en-us

00:10:06

Jefferies London: Protagonist Therapeutics CEO Dinesh...

BiotechTV - News ·

2025/11/18

He covers the company's oral IL-23 (partnered with JNJ), rusfertide (partnered with Takeda), and a new early stage obesity program.

en-us

00:10:09

Jefferies London: BeOne Medicines announced a phase 3...

BiotechTV - News ·

2025/11/17

He hit on earnings, the HER2, degraders, and what BeOne is looking for in potential partners.

en-us

00:10:26

Jefferies London: Sofinnova Partners announced a new...

BiotechTV - News ·

2025/11/17

Chairman and managing partner Antoine Papiernik tells us about the fund and how he expects to deploy it. Plus, the current state of European biotech.

en-us

00:04:41

Jefferies London: Jefferies M&A Banker Chris Roop...

BiotechTV - News ·

2025/11/17

He expects deals to continue in 2026, and says that the bidding wars we have seen recently are likely deal specific.

en-us

00:04:12

Legend Biotech CEO Ying Huang shares a post-earnings...

BiotechTV - News ·

2025/11/13

He describes how Legend is no longer capacity constrained for it's CAR-T treatment, Carvykti, and previews the upcoming ASH conference.

en-us

00:12:26

Apogee will have at lest four key trial readouts for...

BiotechTV - News ·

2025/11/12

CEO Michael Henderson walks us through what will be a busy year for the company.

en-us

00:05:11

Avalo Therapeutics is developing a high affinity...

BiotechTV - News ·

2025/11/12

CEO Garry Neil describes the target and how he believes Avalo's therapy has especially high affinity. Approximately 1% of the population is believe to have HS.

en-us

00:05:58

Stifel's Head of Global Equity Capital Markets Seth...

BiotechTV - News ·

2025/11/12

He says that investors are placing fewer, but larger bets on companies lately, and he expects a 'healthy' IPO market in 2026.

en-us

00:08:36

Sionna Therapeutics is trying to improve the...

BiotechTV - News ·

2025/11/12

CEO Mike Cloonan describes the unmet need for better treatments that exists today in CF, and discusses Sionna's development plans.

en-us

00:12:21

Stifel's I&I expert Alex Thompson shares his take on...

BiotechTV - News ·

2025/11/12

He comments on Kymera, Apogee, Avalo, Veridian, Moonlake, Spyre, and Oruka.

en-us

00:09:22

Celcuity release what it believes is practice...

BiotechTV - News ·

2025/11/11

He discusses the pathway and gedatolisib's ability to cover it holistically. Plus, future plans for filing and additional data in breast cancer and beyond.

en-us

00:06:31

Spyre Therapeutics is developing a basket of...

BiotechTV - News ·

2025/11/11

CEO Cameron Turtle describes the improvements Spyre is making in its therapies. 2026 is going to be a data rich year for IBD.

en-us

00:06:49

Vicore Pharma is leveraging in understanding the...

BiotechTV - News ·

2025/11/11

CEO Ahmed Mousa walks us through the sciences and describes how data stacked up against a synthetic external control that was presented at a medical meeting this summer.

en-us

00:09:37

The early part of 2026 is going to be a key time for...

BiotechTV - News ·

2025/11/11

CEO Curran Simpson describes REGENXBIO's expertise in AAV, and walks us through the company's programs.

en-us

00:08:46

Aardvark Therapeutics' approach to obesity is to...

BiotechTV - News ·

2025/11/11

Founder and CEO Tien Lee describes how Aardvark's approach focuses on the gut-brain axis.

en-us

00:13:15

Stifel's Head of Therapeutics Paul Matteis shares his...

BiotechTV - News ·

2025/11/11

He shares his thoughts on uniQure, Xenon, Alkermes, Compass Pathways, GH Research MindMed, and Dyne.

en-us

00:07:47

Upstream Bio is focused on the TSLP space, and has a...

BiotechTV - News ·

2025/11/11

CEO Rand Sutherland describes TSLP pathway and Upstream's choice to hit the receptor, and how this could define the company's competitive profile.

en-us

409 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter